---
title: "High-Throughput Cardiovascular Phenotyping System @ Novartis"
excerpt: "**Oct 2020 - Jul 2022**<br>I designed and built a system to scale up automated drug screening.<br><img src='https://images.prismic.io/novartis-scrollstory/ZlhcoqWtHYXtT7dG_mini-hearts-lab072.jpg?auto=format%2Ccompress&rect=0%2C177%2C3000%2C1688&w=600'>"
collection: portfolio
---

<hr>

[**Link to article**](https://live.novartis.com/article/how-a-drug-target-challenge-gave-rise-to-a-powerful-technology-platform/intro)

**Context**:
> About a decade ago, the cardiovascular research group at Novartis began investigating a potential drug target for heart failure. But while none of the available methods yielded useful results, a new approach for studying miniature muscles turned out to be a perfect match for what the group needed. The resulting mini-heart platform has since developed into a powerful research tool.

**Problem**:


